Weight-loss surgery is becoming an increasingly popular way to address the obesity crisis, providing hope for some of the 99 million people in the United States who struggle with their weight and health. These surgeries, also known as Bariatric Optimization Programs (BOP), have been clinically shown to be the most effective treatments by far when compared to lifestyle changes and drug therapies alone. However, the success of these operations varies greatly among patients; some experience dramatic weight loss, while others struggle to lose body mass and some even completely gain the lost weight back.
At the University of Basel, Professor Arno Schmidt-Trucksäss is leading the way in investigating how physical activity and fitness can improve weight-loss outcomes after BOP operations. Arno will be the keynote speaker during swissnex’s annual Basel Night, presenting his work and detailing how his research can positively impact people’s weight-loss journey. He will be joined by Professor Frank A.J.L Scheer from the Harvard Medical School and Brigham and Women’s Hospital, whose complementary research provides insight into the underlying factors that could lead to better therapies by taking into account meal timing, as well as other biological time-variant changes. These research projects are funded by the Swiss National Science Foundation (SNSF) and the National Institutes of Health (NIH).
6:00pm Doors Open
6:30pm Welcoming Remarks | swissnex Boston | University of Basel
6:40pm Keynote | Arno Schmidt-Trucksäss, University of Basel
7:00pm Fireside Chat | Frank A.J.L Scheer, Harvard University | Arno Schmidt-Trucksäss,
University of Basel | Moderator TBA
7:45pm Networking Reception
9:00pm Doors Close
Frank A.J.L Scheer
Frank A.J.L. Scheer, PhD is Professor of Medicine at Harvard Medical School (HMS) and the Director of the Medical Chronobiology Program at Brigham and Women’s Hospital (BWH), Boston. Dr. Scheer’s work focuses on influences of the endogenous circadian system and its disruption—such as with shift work—on cardiovascular, pulmonary, and metabolic regulation and disease states, including hypertension, asthma, obesity and diabetes. Since 2005, Dr. Scheer has been funded continuously as Principal Investigator by the National Institutes of Health (NIH). Dr. Scheer has received numerous scientific awards, including the Young Investigator Award by the American Academy of Sleep Medicine, the Neal Miller Award by the Academy of Behavioral Medicine Research, and the Outstanding Scientific Achievement Award by the Sleep Research Society. Dr. Scheer is an Editorial Board Member of several peer-reviewed journals, including the American Journal of Cardiovascular Disease, the Neurobiology of Sleep and Circadian Rhythms, and Journal of Biological Rhythms, is an Associate Editor at the journal SLEEP, and is a Member the Board of Directors of the Sleep Research Society.
Alicia joined swissnex Boston as the Head of Innovation+ in 2019 and is responsible for bridging the technology ecosystems of Boston and Switzerland for startups, corporates and foundations. Before joining swissnex, Alicia worked as a technology scout and consultant, catering to the Open Innovation needs of Fortune 500 companies and the US Government. Alicia also worked as both a laboratory scientist and technology transfer specialist at the National Institutes of Health after earning her doctorate in Molecular Medicine from Boston University.
The University of Basel has an international reputation for outstanding achievements in research and teaching. Founded in 1460, it is the oldest university in Switzerland and has a history of success going back over 550 years. As a comprehensive university offering a wide range of high-quality educational opportunities, the University of Basel attracts students both from Switzerland and around the world. The university has positioned itself amidst international competition in the form of five strategic focal areas: Life Sciences, Visual Studies, Nanosciences, Sustainability and Energy Research and European and Global Studies.